Jeremy Veenstra-VanderWeele uses molecular and translational neuroscience research tools in the pursuit of new treatments for autism.
Jeremy Veenstra-VanderWeele
From this contributor
Why serotonin medications may yet help children with autism
A class of medications used to treat obsessive-compulsive disorder seems to ease compulsive behaviors in adults with autism. Why can't we tell if these medications work similarly in children with the condition?
Why serotonin medications may yet help children with autism
How to evaluate new medications for autism
There are no available medications for treating autism’s core symptoms, but there are several candidates in clinical trials. Jeremy Veenstra-VanderWeele describes the factors researchers must take into account when developing drugs for the disorder.
How to evaluate new medications for autism
Explore more from The Transmitter
Betting blind on AI and the scientific mind
If the struggle to articulate an idea is part of how you come to understand it, then tools that bypass that struggle might degrade your capacity for the kind of thinking that matters most for actual discovery.
Betting blind on AI and the scientific mind
If the struggle to articulate an idea is part of how you come to understand it, then tools that bypass that struggle might degrade your capacity for the kind of thinking that matters most for actual discovery.
PIEZO channels are opening the study of mechanosensation in unexpected places
The force-activated ion channels underlie the senses of touch and proprioception. Now scientists are using them as a tool to explore molecular mechanisms at work in internal organs, including the heart, bladder, uterus and kidney.
PIEZO channels are opening the study of mechanosensation in unexpected places
The force-activated ion channels underlie the senses of touch and proprioception. Now scientists are using them as a tool to explore molecular mechanisms at work in internal organs, including the heart, bladder, uterus and kidney.
Latest iteration of U.S. federal autism committee comes under fire
The new panel “represents a radical departure from all past rosters,” says autism researcher Helen Tager-Flusberg.
Latest iteration of U.S. federal autism committee comes under fire
The new panel “represents a radical departure from all past rosters,” says autism researcher Helen Tager-Flusberg.